Article
Microbiology
Tianli Ma, Jinlong Ru, Jinling Xue, Sarah Schulz, Mohammadali Khan Mirzaei, Klaus-Peter Janssen, Michael Quante, Li Deng
Summary: The study revealed differences in the community composition and functional traits of gut bacteriophages in different stages of esophageal diseases, indicating their potential role in the progression of these diseases.
Article
Immunology
Kai Li, Peipei Duan, Haifa He, Ruijuan Du, Qian Wang, Pengju Gong, Hua Bian
Summary: This study found a significant genetic similarity between Barrett's esophagus and esophageal adenocarcinoma (EAC). Seven hub genes were identified, which were progressively upregulated in the transition from normal esophageal tissues to Barrett's esophagus to EAC. Additionally, these genes were found to play important roles in disease development and potential therapeutic targets. Drug sensitivity analysis also identified potential candidates for inhibiting the progression from Barrett's esophagus to EAC.
JOURNAL OF INFLAMMATION RESEARCH
(2023)
Article
Gastroenterology & Hepatology
Prasad G. Iyer, Amitabh Chak
Summary: Endoscopic surveillance of Barrett's esophagus is crucial for detecting dysplasia and adenocarcinoma, but it has limitations such as subtle appearance of dysplasia and sampling errors. High-resolution white-light endoscopy, electronic chromoendoscopy, and comprehensive sampling are essential for surveillance. Emerging innovations including advanced imaging tools and molecular marker-powered approaches can improve the efficiency of surveillance. Validated quality indicators are needed for further advancement in this field to achieve efficient and effective cancer prevention and treatment.
Article
Oncology
Xiaoyu Wang, Puya Gharahkhani, David M. Levine, Rebecca C. Fitzgerald, Ines Gockel, Douglas A. Corley, Harvey A. Risch, Leslie Bernstein, Wong-Ho Chow, Lynn Onstad, Nicholas J. Shaheen, Jesper Lagergren, Laura J. Hardie, Anna H. Wu, Paul D. P. Pharoah, Geoffrey Liu, Lesley A. Anderson, Prasad G. Iyer, Marilie D. Gammon, Carlos Caldas, Weimin Ye, Hugh Barr, Paul Moayyedi, Rebecca Harrison, R. G. Peter Watson, Stephen Attwood, Laura Chegwidden, Sharon B. Love, David MacDonald, John DeCaestecker, Hans Prenen, Katja Ott, Susanne Moebus, Marino Venerito, Hauke Lang, Rupert Mayershofer, Michael Knapp, Lothar Veits, Christian Gerges, Josef Weismueller, Matthias Reeh, Markus M. Noethen, Jakob R. Izbicki, Hendrik Manner, Horst Neuhaus, Thomas Roesch, Anne C. Boehmer, Arnulf H. Hoelscher, Mario Anders, Oliver Pech, Brigitte Schumacher, Claudia Schmidt, Thomas Schmidt, Tania Noder, Dietmar Lorenz, Michael Vieth, Andrea May, Timo Hess, Nicole Kreuser, Jessica Becker, Christian Ell, Ian Tomlinson, Claire Palles, Janusz A. Jankowski, David C. Whiteman, Stuart MacGregor, Johannes Schumacher, Thomas L. Vaughan, Matthew F. Buas, James Y. Dai
Summary: This study identified novel genetic susceptibility loci for esophageal adenocarcinoma and Barrett esophagus using an eQTL set-based genetic association approach, expanding the pool of genetic susceptibility loci.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
(2022)
Review
Medicine, General & Internal
Prateek Sharma
Summary: Barrett esophagus affects approximately 5% of people in the US and approximately 1% worldwide, with a risk of developing esophageal adenocarcinoma. Management typically includes acid-suppressive medications and periodic surveillance endoscopy.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2022)
Article
Gastroenterology & Hepatology
Tarek Sawas, Shawn A. Zamani, Sarah Killcoyne, Andrew Dullea, Kenneth K. Wang, Prasad G. Iyer, Rebecca C. Fitzgerald, David A. Katzka
Summary: Existing Barrett's esophagus screening guidelines have limitations in detecting prevalent esophageal adenocarcinoma. An optimized approach is needed to identify individuals most suitable for esophageal adenocarcinoma screening, particularly one that does not rely on chronic reflux symptoms.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Pelin Ergun, Sezgi Kipcak, Serhat Bor
Summary: Barrett's esophagus (BE) is a condition resulting from chronic gastroesophageal reflux disease, which may progress to esophageal adenocarcinoma (EAC). The histological dysplasia grade is commonly used as a biomarker, but its effectiveness is limited due to cost and lack of progression in many BE patients. Clinicians require multiple or more quantitative biomarkers for early diagnosis of EAC, which has high mortality. Epigenetic factors in the early stages of neoplastic transformation show promise as predictive biomarkers. This review summarizes current research on DNA methylations, histone modifications, and noncoding RNAs (miRNAs) during the progression from BE dysplasia to EAC.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Review
Oncology
Shanmugarajah Rajendra, Prateek Sharma
Summary: Esophageal cancer is a common malignancy with high mortality worldwide. The number of patients diagnosed with adenocarcinoma, a form of esophageal cancer, has dramatically increased since the 1970s. Known risk factors, such as chronic heartburn, Barrett's esophagus, smoking, and obesity, do not entirely explain this increase. Recent research suggests that high-risk type human papillomavirus may be partially responsible for this anomaly.
Article
Gastroenterology & Hepatology
Tarek Sawas, Saam Dilmaghani, Lovekirat Dhaliwal, Kenneth K. Wang, Prasad G. Iyer, David A. Katzka
Summary: The study found that compared to BE patients, EAC patients had significantly lower rates of heartburn, diabetes, hyperlipidemia, hypertension, nonalcoholic steatohepatitis, and metabolic syndrome. Therefore, optimal strategies for screening for prevalent EAC may need to be adjusted.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2021)
Article
Medicine, General & Internal
Prateek Sharma, Gary W. W. Falk, Menaka Bhor, A. Burak Ozbay, Dominick Latremouille-Viau, Annie Guerin, Sherry Shi, Margaret M. M. Elvekrog, Paul Limburg
Summary: This study addresses the prevalence of GERD, BE, and BERN in the US, as well as the utilization patterns of upper endoscopy. The results show an increase in upper endoscopy utilization from GERD to BE to BERN, and a decrease in time between upper endoscopies as the disease stage progresses from BE to BERN.
Article
Gastroenterology & Hepatology
Joel H. Rubenstein, Amir-Houshang Omidvari, Brianna N. Lauren, William D. Hazelton, Francesca Lim, Sarah Xinhui Tan, Chung Yin Kong, Minyi Lee, Ayman Ali, Chin Hur, John M. Inadomi, Georg Luebeck, Iris Lansdorp-Vogelaar
Summary: The optimal strategy for screening esophageal adenocarcinoma varies by race and sex. White men with GERD symptoms can potentially be screened more intensely than is currently recommended, while screening women may not be cost-effective and could even cause net harm for black women.
Article
Multidisciplinary Sciences
Nan Yi, Hailiang Zhao, Juan He, Xike Xie, Liexin Liang, Guowen Zuo, Mingyue Xiong, Yunxiao Liang, Tingzhuang Yi
Summary: Almost 50% of esophageal adenocarcinoma (EAC) patients are progressed from Barrett's esophagus (BE). However, effective stratification and therapy methods for BE and EAC are still lacking. Differentially expressed genes (DEGs) between BE and EAC were identified through the analysis of two public datasets (GSE26886 and GSE37200), followed by bioinformatics analyses to explore potential biomarkers associated with BE-EAC. The results revealed a number of up- and down-regulated genes, which were highly involved in tumorigenesis according to the GO and KEGG enrichment analysis. In addition, the study identified several potential diagnostic and prognostic biomarkers in BE-EAC.
SCIENTIFIC REPORTS
(2023)
Review
Biochemistry & Molecular Biology
Ksenia Maslenkina, Liudmila Mikhaleva, Maxim Naumenko, Rositsa Vandysheva, Michail Gushchin, Dmitri Atiakshin, Igor Buchwalow, Markus Tiemann
Summary: Barrett's esophagus (BE) is a premalignant lesion that can develop into esophageal adenocarcinoma (EAC). The development of BE is caused by biliary reflux and involves various stem cell origins. The concept of healing has been replaced by the cytokine storm and inflammatory microenvironment, leading to intestinal metaplasia. This review discusses the roles of molecular pathways in the pathogenesis of BE and EAC, including NOTCH, hedgehog, NF-?B, and IL6/STAT3.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Gastroenterology & Hepatology
Zachary L. Smith, Abigail M. Thorgerson, Aprill Z. Dawson, Sachin Wani
Summary: This study provides real-world data on critical outcomes for Barrett's esophagus patients undergoing endoscopic eradication therapy (EET), demonstrating a low risk of incident esophageal adenocarcinoma, all-cause mortality, and the need for esophagectomy.
DIGESTIVE DISEASES AND SCIENCES
(2023)
Article
Pharmacology & Pharmacy
N. T. Kucukmetin, A. Tiftikci, B. Cicek
Summary: The frequency of Barrett esophagus in the studied population differs from that reported in other geographical regions. Advanced age and long segment Barrett esophagus on endoscopic examination are associated with an increased risk of dysplasia and cancer. Larger prospective studies are needed for further validation.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
(2022)